At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Restylane Lyft with Lidocainedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Open-Label, Prospective Study of Cannula Injection of Restylane Lyft With Lidocaine for Cheek Augmentation and the Correction of Age Related Midface Contour Deficiencies
In Brief
A clinical study evaluating Restylane Lyft with Lidocaine for Cheek Augmentation and Midface Contour Deficiencies. Completed, enrolled 60 participants across 4 sites.
Detailed Summary
This is a multi-center, open-label, single-arm study to evaluate an injection tool with Restylane Lyft with Lidocaine for cheek augmentation and correction of age related midface contour deficiencies.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCheek Augmentation, Midface Contour Deficiencies
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartMay 2017
First PostedMay 2017
Primary CompletionOct 2017
TodayJul 2026
First PostedMay 19, 2017
Enrollment StartMay 16, 2017
Primary CompletionOct 31, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.1 years ago
Interventions
Restylane Lyft with Lidocainedevice
a sterile gel of hyaluronic acid (HA)